21
Luye Pharma
2186.HK·HKEXYantai CNFounded 20026,000 employees
Small CappharmaPublicCNSOncology
Platform: Microsphere
Market Cap
$1B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (2186.HK)
Loading 2186.HK stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Miritapinarof | 218-9892 | Phase 2 | 1 | IL-17A | CholangiocarcinomaPancreatic Ca | ||
| Zanunaritide | 218-6942 | Phase 1/2 | 1 | TNFα | FSGS |
SEC Filings & Financial Documents
SEC filings are not available for HKEX-listed companies.
Luye Pharma trades on HKEX (CN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)